Morrell Martha 4

What Happened Martha Morrell, Chief Medical Officer of NeuroPace (NPCE), had 1,341 shares withheld by the company on March 24, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. The withheld shares were valued at $13.27 each, totaling $17,795. This was a tax-withholding disposition (not an open-market sale or purchase).

Key Details

• Transaction date: March 24, 2026; filing date: March 25, 2026 (filed promptly).
• Transaction type/code: F (shares withheld to satisfy tax withholding on vested RSUs).
• Shares withheld/disposed: 1,341 @ $13.27; total value reported $17,795.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — Issuer withheld the stated number of shares on March 24, 2026 to satisfy tax withholding obligations in connection with RSU vesting.
• Filing timeliness: Reported the day after the transaction (no late filing indicated).

Context This is a routine tax-withholding event tied to RSU vesting (a common, administrative transaction) rather than a voluntary sale or purchase that signals insider buying or selling intent. Such withholdings reduce the insider’s outstanding shares but do not represent an open-market sale to third parties. Purchases or open-market sales are generally more informative about insider sentiment than tax-related withholdings.